Timbang, Romy D.
HRN: 26-30-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2024
CEFTRIAXONE 1G (VIAL)
11/30/2024
12/07/2024
IV
1g
Every 12 Hours
DM Foot, Right
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes